Compounds > tenofovir

Page last updated: 2024-08-24

tenofovir and oxybutynin

tenofovir has been researched along with oxybutynin in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Habib, MJ; Zidan, AS	1
Agrahari, V; Banga, AK; Clark, MR; Doncel, GF; Gao, X; Jiang, Y; Peet, MM; Singh, ON; Zhang, W	1

Reviews

1 review(s) available for tenofovir and oxybutynin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

4 other study(ies) available for tenofovir and oxybutynin

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Maximized mucoadhesion and skin permeation of anti-AIDS-loaded niosomal gels. Journal of pharmaceutical sciences, 2014, Volume: 103, Issue:3 Topics: Adenine; Adhesiveness; Administration, Cutaneous; Administration, Intravaginal; Animals; Anti-HIV Agents; Cholesterol; Delayed-Action Preparations; Drug Compounding; Female; Hexoses; In Vitro Techniques; Mucous Membrane; Organophosphonates; Rabbits; Skin; Skin Absorption; Solubility; Surface Properties; Surface-Active Agents; Sus scrofa; Tenofovir; Transdermal Patch; Vagina; Vaginal Creams, Foams, and Jellies	2014
Pharmacokinetics of a weekly transdermal delivery system of tenofovir alafenamide in hairless rats. International journal of pharmaceutics, 2020, May-30, Volume: 582 Topics: Adenine; Administration, Cutaneous; Administration, Oral; Alanine; Animals; Antiviral Agents; Delayed-Action Preparations; Drug Administration Schedule; Drug Compounding; Female; Injections, Intravenous; Proof of Concept Study; Rats, Hairless; Tenofovir; Tissue Distribution; Transdermal Patch; Vagina	2020